RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shirzad Jenab to Substance Withdrawal Syndrome

Back to Details
This is a "connection" page, showing publications Shirzad Jenab has written about Substance Withdrawal Syndrome.
Shirzad Jenab
Connection Strength
0.099
Substance Withdrawal Syndrome
  1. Zhu H, Jenab S, Jones KL, Inturrisi CE. The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat. Brain Res Dev Brain Res. 2003 May 14; 142(2):209-13.
    View in: PubMed
    Score: 0.052
  2. Jones KL, Zhu H, Jenab S, Du T, Inturrisi CE, Barr GA. Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959. Neuropsychopharmacology. 2002 Mar; 26(3):301-10.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support